Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Conditions: Metastatic Clear Cell Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8 Interventions: Procedure: Cytoreductive Nephrectomy; Drug: Active Comparator Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Nephrectomy | Research | Urology & Nephrology